Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia

Behavioral and Brain Functions

Shuai Wang²  Wenqiang Li²  Jingyuan Zhao¹  Hongxing Zhang²  Yongfeng Yang²  Xiujuan Wang²  Ge Yang¹  Luxian Lv² 

[1] Department of Psychiatry, Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang, Medical University, No.388, Jianshe Middle Road, Xinxiang, 453002, China

[2] Henan Key Lab of Biological Psychiatry, Xinxiang Medical University, No.388, Jianshe Middle Road, Xinxiang, 453002, China

关键词: Therapeutic effect;    Symptom;    Age at onset;    Schizophrenia;    Association;    Polymorphism;    Estrogen receptor;   

Others  :  793593
DOI  :  10.1186/1744-9081-9-12

 received in 2012-10-30, accepted in 2013-03-10,  发布年份 2013

【 摘 要 】

Background

Estrogen is believed to play an important role in the central nervous system (CNS) and exert a protective role against schizophrenia. Estrogen receptor alpha (ESRα) mediates the biological action of estrogen. Rs2234693 and rs9340799, single nucleotide polymorphisms of ESRα, may be related to many psychiatric disorders, while their association with schizophrenia has not been clarified.

Methods

Genotypes rs2234693 and rs9340799 were detected in 303 schizophrenic patients and 292 healthy controls in a Chinese population. The positive and negative syndrome scale (PANSS) was used to estimate symptoms and therapeutic effects. The association of these polymorphisms with schizophrenia and clinical characteristics was analyzed by the chi-square test, analysis of variance, and others.

Results

The distribution of genotypes and allele frequencies of rs2234693 and rs9340799 exhibited no significant differences between patients and controls, while haplotypes consisting of these polymorphisms had significant differences. For 2234693, T-allele carriers had an earlier age at onset. CC-homozygote carriers had a higher general psychopathology score and its percentage reduction in male and paranoid patients, respectively. CC-homozygote carriers had a higher tension (G4) and poor impulse control (G14) score, mainly in paranoid patients. Furthermore, patients with the CC homozygote had higher reductions of G4 and G14 scores when treated by aripirazole and risperidone, respectively.

Conclusions

Haplotypes consisting of these two polymorphisms in ESRα may be strongly associated with schizophrenia. The rs2234693 was related to age at onset, general psychopathology, G4 and G14 symptoms, even the therapeutic effect in different groups.

【 授权许可】

   
2013 Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Van Os J, Kapur S: Schizophrenia. Lancet 2009, 374:635-645.
• [2]DA Leung MD, Chue MRC, Psych DP: Sex differences in schizophrenia, a review of the literature. Acta Psychiat Scand 2000, 101:3-38.
• [3]Castle D, Wessely S, Der G, Murray RM: The incidence of operationally defined schizophrenia in Camberwell, 1965–84. Brit J Psychiatry 1991, 159:790-794.
• [4]Goldstein JM, Link BG: Gender and the expression of schizophrenia. J Psychiat Res 1988, 22:141-155.
• [5]Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC: The life course of schizophrenia: age and symptom dimensions. Schizophr Res 1997, 23:15-23.
• [6]Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D: Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995, 152:698-703.
• [7]Grigoriadis S, Seeman MV: The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry 2002, 47:437-442.
• [8]Fink G: The GW harris lecture steroid control of brain and pituitary function. Exp Physiology 1988, 73:257-293.
• [9]Stahl SM: Estrogen makes the brain a sex organ. J Clin Psychiatry 1997, 58:421-422.
• [10]Lindamer LA, Lohr JB, Harris MJ, Jeste DV: Gender, estrogen, and schizophrenia. Psychopharmacology Bull 1997, 33:221-228.
• [11]Maurer K, Riecher-R A: The influence of age and sex on the onset and early course of schizophrenia. Brit J Psychiatry 1993, 162:80-86.
• [12]Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE: Association of estrogen levels with neuropsychological performance in women with schizophrenia. Am J Psychiatry 2001, 158:1134-1139.
• [13]Kulkarni J, Riedel A, De Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J, Burger H: Estrogen—a potential treatment for schizophrenia. Schizophr Res 2001, 48:137-144.
• [14]Speroff L: A clinical understanding of the estrogen receptor. Ann NY Acad Sci 2000, 900:26-39.
• [15]Bollig A, Miksicek RJ: An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription. Mol Endocrinology 2000, 14:634-649.
• [16]Mosselman S, Polman J, Dijkema R: ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996, 392:49-53.
• [17]Ring N, Tantam D, Montague L, Newby D, Black D, Morris J: Gender differences in the incidence of definite schizophrenia and atypical psychosis—focus on negative symptoms of schizophrenia. Acta Psychiat Scand 1991, 84:489-496.
• [18]Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999, 20:358-417.
• [19]Ignaszak-Szczepaniak M, Horst-Sikorska W, Dytfeld J, Marcinkowska M, Słomski R, Stajgis M: Association between estrogen receptor alpha gene polymorphisms and bone mineral density in Polish female patients with Graves’ disease. Acta Biochim Pol 2011, 58:101-109.
• [20]Munshi A, Sharma V, Kaul S, Al-Hazzani A, Alshatwi AA, Manohar VR, Rajeshwar K, Babu MS, Jyothy A: Estrogen receptor [alpha] genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh. Clin Chim Acta 2010, 411:1817-1821.
• [21]Ma SL, Tang NLS, Tam CWC, Lui VWC, Lau ESS, Zhang YP, Chiu HFK, Lam LCW: Polymorphisms of the estrogen receptor α (ESR1) gene and the risk of Alzheimer’s disease in a southern Chinese community. Int Psychogeriatrics 2009, 21:977-986.
• [22]Tsai SJ, Wang YC, Hong CJ, Chiu HJ: Association study of oestrogen receptor [alpha] gene polymorphism and suicidal behaviours in major depressive disorder. Psychiat Genet 2003, 13:19-22.
• [23]Tiemeier H, Schuit S, Den Heijer T, Van Meurs J, Van Tuijl H, Hofman A, Breteler M, Pols H, Uitterlinden A: Estrogen receptor α gene polymorphisms and anxiety disorder in an elderly population. Mol Psychiatry 2005, 10:806-807.
• [24]McClellan JM, Susser E, King M-C: Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 2007, 190:194-199.
• [25]Arinami T, Gao M, Hamaguchi H, Toru M: A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997, 6:577-582.
• [26]Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, Radhakrishna V, Straub RE, Weinberger DR, Kleinman JE: Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008, 17:2293-2309.
• [27]Martorell L, Costas J, Valero J, Gutierrez-Zotes A, Phillips C, Torres M, Brunet A, Garrido G, Carracedo A, Guillamat R: Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophr Res 2008, 100:308-315.
• [28]Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Okumura T, Tsunoka T, Inada T: Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population. Psychiat Genet 2009, 19:217-218.
• [29]Yong Y, Lin H: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
• [30]Anttila S, Kampman O, Illi A, Roivas M, Mattila KM, Lassila V, Lehtimäki T, Leinonen E: NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia. Psychiat Genet 2003, 13:61-63.
• [31]Solé X, Guinó E, Valls J, Iniesta R, Moreno V: SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
• [32]Alonso P, Gratacos M, Segalas C, Escaramis G, Real E, Bayés M, Labad J, Pertusa A, Vallejo J, Estivill X: Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder. Psychoneuroendocrinology 2011, 36:473-483.
• [33]Purcell S, Cherny SS, Sham PC: Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
• [34]Ouyang WC, Wang YC, Hong CJ, Tsai SJ: Estrogen receptor [alpha] gene polymorphism in schizophrenia: frequency, age at onset, symptomatology and prognosis. Psychiat Genet 2001, 11:95-98.
• [35]Cardno AG, Holmans PA, Rees MI, Jones LA, McCarthy GM, Hamshere ML, Williams NM, Norton N, Williams HJ, Fenton I: A genomewide linkage study of age at onset in schizophrenia*. Am J Med Genet 2001, 105:439-445.
• [36]Chen WJ, Yeh LL, Chang CJ, Lin LC, Rin H, Hwu HG: Month of birth and schizophrenia in Taiwan: effect of gender, family history and age at onset. Schizophr Res 1996, 20:133-143.
• [37]Fanous A, Kendler K: Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 2005, 10:6-13.
• [38]Li WJ, Kou CG, Yu Y, Sun S, Zhang X, Kosten TR, Zhang XY: Association of Catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population. Am J Med Genet B 2012, 159B:370-375.
• [39]Green PS, Simpkins JW: Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 2000, 18:347-358.
• [40]Östlund H, Keller E, Hurd YL: Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann NY Acad Sci 2003, 1007:54-63.
• [41]Österlund MK, Hurd YL: Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiology 2001, 64:251-267.
• [42]Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER: Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. New Engl J Med 2002, 346:967-974.